With Anthem funding, OACHC directs $100,000 to provide test kits, generators, tents, protective gear and other necessary equipment
Columbus, Ohio – As coronavirus disease 2019 (COVID-19) cases again rise across Ohio, 20 community health centers serving many of the state’s most challenged communities are receiving much-needed funds to support accelerated COVID-19 testing. Anthem Blue Cross and Blue Shield in Ohio is giving $100,000 to the Ohio Association of Community Health Centers, who will disperse the funds to member health centers across the state. This is part of Anthem’s ongoing commitment to the people and communities it serves, and to provide greater access to care throughout this pandemic.
Community health centers have been at the forefront of the COVID-19 pandemic, providing healthcare to medically underserved populations in rural and urban settings. Ohio’s community health centers, 56 in total, provide affordable, quality, whole person care that includes medical, dental, behavioral health, pharmacy, vision and supplemental services to more than 850,000 Ohioans. Each center is designated as a Federally Qualified Health Center/FQHC Look-Alike by HHS.
“We stand with Ohio communities, as we have for more than 60 years, to keep people safe and continue to work toward healthcare equality for all,” explained Tiffany Inglis, MD, medical director at Anthem Blue Cross and Blue Shield in Ohio. “As we battle with COVID-19, it’s critical that we ramp up testing across the state and nowhere is that more important than areas served by community health centers. These funds will go a long way to increasing critical access to testing.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More